2 Methods 2.1 Eligibility criteria This meta-analysis was registered prospectively in PROSPERO (CRD420251147337) and was carried out following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) recommendations
Do not exceed the expressly recommended daily dose
& Milos, R
Ruze R, Liu T, Zou X, Song J, Chen Y, Xu R, Yin X, Xu Q (2023) Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments
Others still lose inches, gain strength or feel better even when the number on the scale changes slowly
However, there is currently no strong scientific evidence showing that semaglutide directly triggers hormone-related ovarian cyst formation